• Analytical sampling methods for substances with an ACGIH TLV
• Impact of fuel selection during live fire training on firefighter exposures to carcinogens
• Factors for musculoskeletal injury (MSI) in rated (metric) work systems

The PCC Fellowship Program supports qualified scientists interested in the field of anti-doping, committed to meaningful research, and demonstrating potential for long-term contribution to the field of anti-doping scien​ce. Fellows selected by the PCC participate in a two-year program. Fellows gain practical knowledge from a U.S.-based, WADA-accredited laboratory and conduct research supporting the anti-doping field.

With an emphasis on original work that focuses on improving existing analytical methods for detecting particular drugs, developing new analytical methods to test for substances not currently detectable, and discovering cost-effective approaches for testing widely abused substances across all levels of sport, the following areas of investigation reflect the PCC’s current research priorities:

• Developing methods of cost-effective testing to detect and deter the use of prohibited substances and methods.
• Developing novel testing protocols to detect and deter new or designer substances or methods used to evade detection (e.g., micor-dosing) for doping purposes.
• Improving existing chromatography-mass spectrometry and other analytical chemistry or biomedical methods to detect particular drugs, ex. GH, IGF-1, EPO, hCG.
• Developing new analytical methods to detect performance enhancing drugs not currently detectable.
• Examination of pharmacokinetic/pharmacodynamics of doping substances through human administration studies examining longitudinal urinary excretion patterns, metabolism, and dose-concentration, including confounding factors that may influence excretion, detection, or performance-enhancing impact. This also includes studies which aim to differentiate between sources of contamination and doping by identifying novel discriminate urinary or blood markers or metabolites, or ratios thereof, through well-designed human administration studies.
• Critical reviews to support interpretation of laboratory data.
• The application of alternative specimens, (ex. oral fluid, dried blood/plasma spots) for testing and analysis.
• Discovery and validation of specific and sensitive biomarkers in urine and/or blood for the purposes of the Athlete Biological Passport (ABP) that aim to indirectly identify the use of doping substances or methods.
• Detection of prohibited gene doping, gene editing, gene silencing technologies, as well as the detection of prohibited stem cell therapies.
• Artificial intelligence, machine learning, and other related research that leads to optimization of anti-doping testing programs.
• Development of effective quantitative and qualitative measures of doping deterrence and education through well-designed survey methods applicable to multiple athlete domains and social science research.

The Burroughs Wellcome Fund aims to stimulate the growth of new connections between thinkers working in largely disconnected fields, who, together, may change the course of climate change’s impact on human health. Between Fall 2023 and Summer 2026, we will dedicate $1 million to supporting small, early-stage grants of $2,500–$50,000 toward achieving this goal.

We are primarily, but not exclusively, interested in activities that build connections between basic and early biomedical scientific approaches and ecological, environmental, geological, geographic, and planetary-scale thinking, as well as with population-focused fields, including epidemiology and public health, demography, economics, and urban planning. Also of interest is work piloting new approaches or interactions aimed at reducing the impact of health-centered activities, such as developing more sustainable systems for healthcare, care delivery, and biomedical research.

The specific objectives of this funding opportunity are to support:

• planning activities, partnership development and to increase understanding of the health research landscape that will contribute to the advancement of research consistent with the mandate of CIHR; and
• dissemination events and activities that focus on the communication of health research evidence to the appropriate researcher or knowledge-user audiences, tailoring the message and medium as appropriate.

The objective of the Exploration stream is to support high-risk, high-reward and interdisciplinary research. It seeks to inspire projects that bring disciplines together beyond traditional disciplinary or common interdisciplinary approaches by research teams with the capacity to explore something new that might fail, but that has the potential for significant impact.

These grants support events and outreach activities geared toward short-term, targeted knowledge mobilization initiatives. These events and activities represent opportunities to exchange knowledge and engage with participants on research issues they value. Events and outreach activities funded by a Connection Grant can often serve as a first step toward more comprehensive and longer-term projects.

Connection Grants support workshops, colloquiums, conferences, forums, summer institutes, documentaries or other events or outreach activities that facilitate:

• disciplinary and/or interdisciplinary exchanges in the social sciences and humanities;
• scholarly exchanges between those working in the social sciences and humanities and those working in other research fields;
• intersectoral exchanges between academic researchers in the social sciences and humanities and researchers and practitioners from the public, private and/or not-for-profit sectors; and/or
• international research collaboration and scholarly exchanges with researchers, students and non-academic partners from other countries.

Discovery Horizons grants support investigator-initiated individual and team projects that broadly integrate or transcend disciplines to advance knowledge in the natural sciences and engineering (NSE).

Established in 2021 by the Social Sciences and Humanities Research Council (SSHRC), the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council of Canada (NSERC), the Tri-agency Interdisciplinary Peer Review Committee (TAIPR) is dedicated to the review of interdisciplinary research. This jointly administered tri-agency peer review committee will assess all full applications submitted to NSERC’s Discovery Horizons pilot program, as well as relevant applications submitted to SSHRC’s Insight Grants and Insight Development Grants and CIHR’s Project Grants programs.

In the context of this funding opportunity, the term “interdisciplinary” should be understood to fully encompass all research that connects, crosses or falls in between the traditional disciplines of the three agencies, including transdisciplinary, multidisciplinary, convergence research and other approaches at the interface.

Discovery Horizons grants are expected to be valued from $50,000 to $100,000 per year and will be commensurate to the size of the research team (applicant and co-applicant(s), as indicated in the Team composition table). For this competition, NSERC is expecting to award approximately 10 to 20 grants this year.

The DG program supports ongoing programs of research with long-term goals rather than a single short-term project or collection of projects. These grants recognize the creativity and innovation that are at the heart of all research advances. DGs are typically five years in duration and are considered “grants in aid” of research, as they provide long-term operating funds and can facilitate access to funding from other programs but are not meant to support the full costs of a research program.

The DHDP is launching a Request for Applications for the Digital Health Innovation Fund. The purpose of this opportunity is to support the development of research programs through their use of the Platform. While the fund prioritizes oncology and neurology research programs, the DHDP is a disease agnostic initiative. Applications focused on other areas of health and AI research where similar data may be available (eg. diabetes, cardiology) will also be considered. By identifying and selecting research initiatives for their compelling science, projects will advance the design and use of the Platform to support meaningful and impactful projects. In parallel, the intention is to stimulate collaboration among small- and medium- sized enterprises (SMEs), while adopting a view toward the commercialization potential of research discoveries.